Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ProEthic plans pain relief product launches for 2008

May 12, 2006

Merck Sharp and Dohme presents novel NK-1R antagonists

May 11, 2006

RN-624 relieves pain from knee osteoarthritis

May 11, 2006

Study data reveal analgesic profile of tapentadol

May 11, 2006

Lilly seeks approval of Cymbalta for generalized anxiety disorder

May 10, 2006

Eisai plans phase I study for E-2012 for Alzheimer's disease

May 10, 2006

ACR-16 improves Huntington's disease symptoms in phase II study

May 10, 2006

Phase II studies show reduced pain with ALGRX-4975 in lateral epicondylitis, neuroma

May 10, 2006

ALGRX-3268 local analgesia effective in children

May 10, 2006

Update on lacosamide at American Pain Society

May 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...